Elevated level of circulating calprotectin correlates with severity and high mortality in patients with COVID-19.

Haoran ZhangQingyu ZhangKun LiuZenong YuanXiqiang XuJun Dong

Published in: Immunity, inflammation and disease (2024)

This meta-analysis showed that calprotectin was elevated in patients with severe COVID-19, and this atypical inflammatory cytokine might serve as a useful biomarker to distinguish the severity of COVID-19 and predict the prognosis.

Keyphrases

coronavirus disease
sars cov
systematic review
disease activity
cardiovascular events
respiratory syndrome coronavirus
early onset
randomized controlled trial
rheumatoid arthritis
type diabetes
cardiovascular disease
systemic lupus erythematosus
case control